{"title": "Takeda: sale Wolfgang, entra Kassis", "author": "Cristina Kroll", "url": "https://www.pharmabiz.net/takeda-sale-wolfgang-entra-kassis/", "hostname": "pharmabiz.net", "description": "Bilingual Version Luego de ponerle el cintur\u00f3n a la filial argentina, el laboratorio japon\u00e9s Takeda design\u00f3 a un nuevo n\u00famero uno en el pa\u00eds. Se trata de Jack Kassis Makdsi, que viene desde Takeda Venezuela, donde cumpl\u00eda el rol de director Comercial. El nuevo ejecutivo remplaza al alem\u00e1n Wolfgang Schmidt que estuvo los \u00faltimos 12...", "sitename": "PharmaBiz.NET", "date": "2013-04-18", "cleaned_text": "Luego de ponerle el cintur\u00f3n a la filial argentina, el laboratorio japon\u00e9s Takeda design\u00f3 a un nuevo n\u00famero uno en el pa\u00eds. Se trata de Jack Kassis Makdsi, que viene desde Takeda Venezuela, donde cumpl\u00eda el rol de director Comercial. El nuevo ejecutivo remplaza al alem\u00e1n Wolfgang Schmidt que estuvo los \u00faltimos 12 a\u00f1os en Takeda Argentina, ocho como CFO y los cuatro \u00faltimos como gerente general. Kassis deber\u00e1 hacerle frente a una Takeda reducida que busca su rumbo en la Argentina. [Ver art\u00edculo](https://www.pharmabiz.net/takeda-achique-o-expansion/). Los motivos que encontraron los japoneses para achicarse fue que evaluaron como caros los resultados de sus costos de producci\u00f3n. Sucedi\u00f3 que tras el cierre de la planta de producci\u00f3n de HLB Pharma en el barrio porte\u00f1o de Belgrano, se vieron compelidos a buscar otra unidad de control de calidad, ya que subarrendaban dicha planta. Se instalaron a principios de a\u00f1o en la unidad de log\u00edstica de la empresa Cruz del Sur ubicada en el Mercado Central, donde operara la ex Wyeth. La cotizaci\u00f3n del d\u00f3lar tambi\u00e9n sin duda pes\u00f3 en las \u00faltimas decisiones de Takeda, al igual que sucedi\u00f3 con Baxter. Mientras, otras multis intentan hacer equilibrio. [Ver art\u00edculo](https://www.pharmabiz.net/baxter-dolar-foco-y-latam/). __________________________________________________________________________________________ Thursday 18, April 2013 Takeda: Wolfgang Out, Kassis In After working on the reduction of the Argentine subsidiary, the Japanese laboratory Takeda appointed a new number one in the country. It is Jack Kassis Makdsi, who was the commercial director of Takeda Venezuela. The new executive replaces the German Wolfgang Schmidt, who was with Takeda Argentina for the last 12 years\u2014the first 8 years as CFO and the last 4 years as general manager. Kassis should deal with a reduced Takeda that is looking for direction in Argentina. [See article.](https://www.pharmabiz.net/takeda-achique-o-expansion/) The reasons for the reduction were that the Japanese considered that their production costs were high. After the shutdown of HLB Pharma's production plant in Belgrano neighborhood, Autonomous City of Buenos Aires, they were compelled to search for another Quality Control unit, since they sublet this plant. At the beginning of the year, they settled in the Logistics unit of the company Cruz del Sur, which is located at the Central Market, where ex Wyeth operated. The dollar quotation certainly influenced the latest decisions made by Takeda as well, as it happened in the case of Baxter. Meanwhile, other multinationals try to "}